These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
609 related items for PubMed ID: 19933662
21. Preoperative transcatheter selective arterial chemoembolization in treatment of unresectable hepatoblastoma in infants and children. Li JP, Chu JP, Yang JY, Chen W, Wang Y, Huang YH. Cardiovasc Intervent Radiol; 2008; 31(6):1117-23. PubMed ID: 18560935 [Abstract] [Full Text] [Related]
22. Survival, efficacy, and safety of small versus large doxorubicin drug-eluting beads TACE chemoembolization in patients with unresectable HCC. Prajapati HJ, Xing M, Spivey JR, Hanish SI, El-Rayes BF, Kauh JS, Chen Z, Kim HS. AJR Am J Roentgenol; 2014 Dec; 203(6):W706-14. PubMed ID: 25415737 [Abstract] [Full Text] [Related]
23. Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib. Pinter M, Hucke F, Graziadei I, Vogel W, Maieron A, Königsberg R, Stauber R, Grünberger B, Müller C, Kölblinger C, Peck-Radosavljevic M, Sieghart W. Radiology; 2012 May; 263(2):590-9. PubMed ID: 22438359 [Abstract] [Full Text] [Related]
24. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion. Kim KM, Kim JH, Park IS, Ko GY, Yoon HK, Sung KB, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ. J Gastroenterol Hepatol; 2009 May; 24(5):806-14. PubMed ID: 19207681 [Abstract] [Full Text] [Related]
25. Treatment of hepatocellular carcinoma using arterial chemoembolization with degradable starch microspheres and continuous arterial infusion of 5-fluorouracil. Ishida K, Hirooka M, Hiraoka A, Kumagi T, Uehara T, Hiasa Y, Horiike N, Onji M. Jpn J Clin Oncol; 2008 Sep; 38(9):596-603. PubMed ID: 18772170 [Abstract] [Full Text] [Related]
26. [Transcatheter arterial chemoembolization technique in cirrhotic patients with hepatocarcinoma. Considerations on the procedure and evaluation of survival]. Roversi R, Milandri GL, Ricci S, Rossi G, Dal Monte PR. Radiol Med; 1994 Dec; 88(6):834-9. PubMed ID: 7878244 [Abstract] [Full Text] [Related]
27. MWA combined with TACE as a combined therapy for unresectable large-sized hepotocellular carcinoma. Liu C, Liang P, Liu F, Wang Y, Li X, Han Z, Liu C. Int J Hyperthermia; 2011 Dec; 27(7):654-62. PubMed ID: 21966941 [Abstract] [Full Text] [Related]
28. Superselective transarterial chemoembolization vs hepatic resection for resectable early-stage hepatocellular carcinoma in patients with Child-Pugh class a liver function. Hsu KF, Chu CH, Chan DC, Yu JC, Shih ML, Hsieh HF, Hsieh TY, Yu CY, Hsieh CB. Eur J Radiol; 2012 Mar; 81(3):466-71. PubMed ID: 21376495 [Abstract] [Full Text] [Related]
29. Safety and efficacy of transcatheter arterial chemoembolization with embospheres in treatment of hepatocellular carcinoma. Hao MZ, Lin HL, Chen QZ, Hu YB, Chen JB, Zheng JX, Zhou D, Zhang H. J Dig Dis; 2017 Jan; 18(1):31-39. PubMed ID: 27987344 [Abstract] [Full Text] [Related]
31. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate. Dohmen K, Shirahama M, Shigematsu H, Miyamoto Y, Torii Y, Irie K, Ishibashi H. Hepatogastroenterology; 2001 Jan; 48(41):1409-15. PubMed ID: 11677976 [Abstract] [Full Text] [Related]
32. Transarterial chemoembolization for hepatocellular carcinoma after transjugular intrahepatic portosystemic shunt. Kang JW, Kim JH, Ko GY, Gwon DI, Yoon HK, Sung KB. Acta Radiol; 2012 Jun 01; 53(5):545-50. PubMed ID: 22547388 [Abstract] [Full Text] [Related]
33. [Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for massive primary liver cancer]. Sun HW, Chen LH, Wei CJ, Zheng XK, Li QS, Guan J. Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jun 01; 29(6):1133-6. PubMed ID: 19726341 [Abstract] [Full Text] [Related]
34. [Transcatheter hepatic arterial chemoembolization on recurrent hepatocellular carcinoma after resection]. Ge NL, Ren ZG, Ye SL, Lin ZY, Xia JL, Gan YH, Li LX, Shen YF, Tang ZY. Zhonghua Zhong Liu Za Zhi; 2005 Jun 01; 27(6):380-2. PubMed ID: 16117905 [Abstract] [Full Text] [Related]
35. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of damage to nontumorous liver tissue-long-term prospective study. Caturelli E, Siena DA, Fusilli S, Villani MR, Schiavone G, Nardella M, Balzano S, Florio F. Radiology; 2000 Apr 01; 215(1):123-8. PubMed ID: 10751477 [Abstract] [Full Text] [Related]
36. A comparative study of damage to liver function after TACE with use of low-dose versus conventional-dose of anticancer drugs in hepatocellular carcinoma. Lu W, Li YH, Yu ZJ, He XF, Chen Y, Zhao JB, Zhu ZY. Hepatogastroenterology; 2007 Apr 01; 54(77):1499-502. PubMed ID: 17708284 [Abstract] [Full Text] [Related]
37. Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors. Ueno K, Miyazono N, Inoue H, Nishida H, Kanetsuki I, Nakajo M. Cancer; 2000 Apr 01; 88(7):1574-81. PubMed ID: 10738215 [Abstract] [Full Text] [Related]
38. Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC). Dhanasekaran R, Kooby DA, Staley CA, Kauh JS, Khanna V, Kim HS. J Surg Oncol; 2010 May 01; 101(6):476-80. PubMed ID: 20213741 [Abstract] [Full Text] [Related]
40. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Takayasu K, Arii S, Ikai I, Omata M, Okita K, Ichida T, Matsuyama Y, Nakanuma Y, Kojiro M, Makuuchi M, Yamaoka Y, Liver Cancer Study Group of Japan. Gastroenterology; 2006 Aug 01; 131(2):461-9. PubMed ID: 16890600 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]